Skip to main content
Premium Trial:

Request an Annual Quote

Shares of Genomic Health, Thermo Fisher and Invitrogen Rise on Strong Q4 Results

NEW YORK (GenomeWeb News) – Shares of Genomic Health, Thermo Fisher Scientific, and Invitrogen rose significantly today after all three firms posted strong fourth-quarter results.
Genomic Health led the charge, with its shares rising 16 percent to $23.04 in mid-afternoon trade on the Nasdaq. After the close of the market yesterday, the firm said that its revenues for the quarter ended Dec. 31, 2007, grew by 124 percent to $19.3 million from $8.6 million in the fourth quarter of 2006, while cutting its net loss by a third.
Thermo Fisher Scientific’s shares were up 7.5 percent at $54 on the New York Stock Exchange after the firm reported this morning that its fourth-quarter revenues rose 12 percent on a pro forma basis to $2.62 billion.
Thermo Fisher also posted a fourth-quarter profit of $239.8 million, or $.54 per share. The reported revenues and profit beat analysts’ expectations.
Invitrogen gained 6.2 percent to $88.58 in afternoon trade on the Nasdaq after it reported 12 percent revenue growth to $336.4 million for the fourth quarter. The firm also posted net income of $41.1 million, or $.83 per share, compared to a net loss of $100.2 million, or $2.03 million per share.

The Scan

Pig Organ Transplants Considered

The Wall Street Journal reports that the US Food and Drug Administration may soon allow clinical trials that involve transplanting pig organs into humans.

'Poo-Bank' Proposal

Harvard Medical School researchers suggest people should bank stool samples when they are young to transplant when they later develop age-related diseases.

Spurred to Develop Again

New Scientist reports that researchers may have uncovered why about 60 percent of in vitro fertilization embryos stop developing.

Science Papers Examine Breast Milk Cell Populations, Cerebral Cortex Cellular Diversity, Micronesia Population History

In Science this week: unique cell populations found within breast milk, 100 transcriptionally distinct cell populations uncovered in the cerebral cortex, and more.